2014
DOI: 10.1111/cen.12575
|View full text |Cite
|
Sign up to set email alerts
|

Reduced beta‐cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation

Abstract: SummaryBackground Impaired glucose tolerance (IGT) and diabetes mellitus (DM) occur more frequently after bone marrow transplantation and total body irradiation (BMT/TBI), but the mechanism is unclear. This study investigates insulin sensitivity, b-cell reserve and pancreatic volume in adult survivors of childhood acute lymphoblastic leukaemia (ALL). Method Survivors (aged 16-26 years) of ALL treated with BMT/TBI (10-14Á4 Gy) Group 1 (n = 20, 10 M) were compared with a chemotherapy-only Group 2 (n = 28, 11 M).… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 38 publications
(76 reference statements)
2
23
0
1
Order By: Relevance
“…Adiponectin, a marker of adipocyte function which correlates with insulin sensitivity, was reduced in HSCT/TBI survivors, consistent with previous findings . The observation of a negative correlation between adiponectin and length of time post treatment in HSCT/TBI survivors suggests that cardiometabolic outcomes may worsen with time, in line with the evolving risk of impaired glucose tolerance and reduced insulin sensitivity …”
Section: Discussionsupporting
confidence: 89%
“…Adiponectin, a marker of adipocyte function which correlates with insulin sensitivity, was reduced in HSCT/TBI survivors, consistent with previous findings . The observation of a negative correlation between adiponectin and length of time post treatment in HSCT/TBI survivors suggests that cardiometabolic outcomes may worsen with time, in line with the evolving risk of impaired glucose tolerance and reduced insulin sensitivity …”
Section: Discussionsupporting
confidence: 89%
“…Our results point to the opposite direction and suggest that BMT may lead to metabolic abnormalities, including reduced insulin secretion and glucose intolerance, which is specifically manifest on HFD. Interestingly, reduced pancreas volume was also observed in survivors of childhood acute lymphoblastic leukaemia who were treated with BMT [19]. In line with our study, several clinical studies suggests that BMT survivors have an increased risk of developing insulin resistance and T2D development [16,10,20].…”
Section: Discussionsupporting
confidence: 87%
“…Insulin resistance was reported in as many as 52% of longterm HSCT survivors (189). Diabetes and insulin resistance do not seem to be related to obesity, as measured by BMI, in this population (190,191); their pathophysiology seems to involve abnormal body fat distribution and possibly pancreatic islet cell injury due to TBI (192,193). Survivors of solid tumors requiring treatment with abdominal radiotherapy may also have a higher risk of glucose intolerance and diabetes mellitus (76,194,195,196,197).…”
Section: Prevalence and Risk Factorsmentioning
confidence: 83%